113 related articles for article (PubMed ID: 2559183)
1. Hydrolysis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) in rabbit and human plasma and its release from oily solution.
Fukushima S; Hayashi Y; Kawaguchi T; Kaneko M; Nakano M
J Pharmacobiodyn; 1989 Aug; 12(8):495-502. PubMed ID: 2559183
[TBL] [Abstract][Full Text] [Related]
2. Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol.
Kawaguchi T; Fukushima S; Hayashi Y; Kaneko M; Nakano M
Cancer Res; 1988 Aug; 48(15):4179-83. PubMed ID: 2839289
[TBL] [Abstract][Full Text] [Related]
3. Selective anticancer effects of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine, a lipophilic prodrug of 5-fluoro-2'-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor.
Fukushima S; Kawaguchi T; Nishida M; Juni K; Yamashita Y; Takahashi M; Nakano M
Cancer Res; 1987 Apr; 47(7):1930-4. PubMed ID: 3028618
[TBL] [Abstract][Full Text] [Related]
4. The achievement of mass balance by simultaneous quantification of floxuridine prodrug, floxuridine, 5-fluorouracil, 5-dihydrouracil, α-fluoro-β-ureidopropionate, α-fluoro-β-alanine using LC-MS.
Tsume Y; Provoda CJ; Amidon GL
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):915-20. PubMed ID: 21450537
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent elimination of 5-fluoro-2'-deoxyuridine in the monkey.
Williams WM; Huang KC; Chen TS; Warren BS
Proc Soc Exp Biol Med; 1987 Mar; 184(3):326-36. PubMed ID: 2950526
[TBL] [Abstract][Full Text] [Related]
6. A new class of 5-fluoro-2'-deoxyuridine prodrugs conjugated with a tumor-homing cyclic peptide CNGRC by ester linkers: synthesis, reactivity, and tumor-cell-selective cytotoxicity.
Zhang Z; Hatta H; Tanabe K; Nishimoto S
Pharm Res; 2005 Mar; 22(3):381-9. PubMed ID: 15835743
[TBL] [Abstract][Full Text] [Related]
7. Specificity of esterases and structures of prodrug esters. III. Activity of rat tissue homogenates, rat plasma and porcine liver esterase for the hydrolysis of 3',5'-bis-dicarboxylic acid hemiesters of 5-fluoro-2'-deoxyuridine.
Kawaguchi T; Suzuki Y; Nambu N; Nagai T
Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2956-61. PubMed ID: 2935265
[No Abstract] [Full Text] [Related]
8. Intraarterial infusion of 5-fluoro-2-deoxyuridine-C8 dissolved in a lymphographic agent in malignant liver tumors. A preliminary report.
Yamashita Y; Takahashi M; Bussaka H; Fukushima S; Kawaguchi T; Nakano M
Cancer; 1989 Dec; 64(12):2437-44. PubMed ID: 2555039
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of novel antitumor prodrugs of 5-fluoro-2'-deoxyuridine activated by hypoxic irradiation.
Shibamoto Y; Tachi Y; Tanabe K; Hatta H; Nishimoto S
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):397-402. PubMed ID: 14751508
[TBL] [Abstract][Full Text] [Related]
10. Release characteristics of a free polyunsaturated fatty acid from an oily lymphographic agent.
Hayashi Y; Fukushima S; Kishimoto S; Nakano M
Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2874-6. PubMed ID: 1963816
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluoro-2'-deoxyuridine elimination by the isolated perfused rat liver.
Csaky KG; LaCreta FP; Warren BS; Williams WM
Cancer Res; 1988 Jul; 48(13):3561-5. PubMed ID: 2967734
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new lipophilic prodrug 3', 5'-dioctanoyl-5-bromodeoxyuridine (BrdU-C8) suspended in Lipiodol as a radiosensitizer for the treatment of AH136B tumor.
Ohara C; Beppu T; Yamaguchi Y; Masuda Y; Fukushima S; Kawaguchi T; Ogawa M
Anticancer Res; 1993; 13(3):655-60. PubMed ID: 8391245
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoassay for the detection and quantitation of 5-fluorodexoyuridine.
Schreiber R; Raso V
Cancer Res; 1978 Jul; 38(7):1889-92. PubMed ID: 148966
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine.
Muggia FM; Chan KK; Russell C; Colombo N; Speyer JL; Sehgal K; Jeffers S; Sorich J; Leichman L; Beller U
Cancer Chemother Pharmacol; 1991; 28(4):241-50. PubMed ID: 1831736
[TBL] [Abstract][Full Text] [Related]
15. Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.
De Flora A; Zocchi E; Guida L; Polvani C; Benatti U
Proc Natl Acad Sci U S A; 1988 May; 85(9):3145-9. PubMed ID: 2966399
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
[TBL] [Abstract][Full Text] [Related]
17. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
[TBL] [Abstract][Full Text] [Related]
18. Specificity of esterases and structure of prodrug esters. II. Hydrolytic regeneration behavior of 5-fluoro-2'-deoxyuridine (FUdR) from 3',5'-diesters of FUdR with rat tissue homogenates and plasma in relation to their antitumor activity.
Kawaguchi T; Saito M; Suzuki Y; Nambu N; Nagai T
Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1652-9. PubMed ID: 2931191
[No Abstract] [Full Text] [Related]
19. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs.
Shibamoto Y; Mimasu Y; Tachi Y; Hatta H; Nishimoto S
J Chemother; 2002 Aug; 14(4):390-6. PubMed ID: 12420858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
